Department of Internal Medicine

Hematology, Oncology and Blood &  Marrow Transplantation Faculty


Raymond Hohl photo

Medical School:
Rush Medical College

Residency:
University of Chicago

Fellowship:
University of Chicago

Special Training:
Rush University, Pharmacology

Raymond J. Hohl, M.D., Ph.D.
Holden Family Chair
Professor of Medicine and Pharmacology
Associate Chair, Department of Internal Medicine
Associate Director for Translational Research, Holden Comprehensive Cancer Center

Dr. Hohl's research interests focus on understanding the interactions between mevalonic acid and cholesterol biosynthesis and the proliferation of acute myeloid leukemia cells. These studies investigate the relative affinities of various growth regulating proteins, such as RAS and KREV1, for the isoprene intermediates of the mevalonic acid to cholesterol biosynthetic pathway. His clinical interests involve evaluation of the potential role for pharmacologic inhibitors of this biosynthetic pathway in the treatment of various hematologic malignancies and solid tumors. Additionally, he has continued interest in studying how various erythrocyte enzymothathies predispose the human red blood cell to drug-induced oxidative damage.

Honors, Awards, and Organizations

Recent Publications

  1. Hamadmad, S., Henry, M., Hohl, R.J.: Erythropoietin Receptor Signal Transduction Requires Protein Geranylgeranylation, Journal of Pharmacology and Experimental Therapeutics, 316(1): 403-409, 2006.
  2. Holstein, S.A., Knapp, H.R., Clamon, G.H., Murry, D.J., Hohl, R.J.: Pharmacodynamic Effects of High Dose Lovastatin in Subjects with Advanced Malignancies, Cancer Chemotherapy and Pharmacology, 57(2): 155-164, 2006.
  3. Murthy, S., Tong, H., Hohl, R.J.: Regulation of Fatty Acid Synthesis by Farnesyl Pyrophosphate, Journal of Biological Chemistry, 280 (51): 41793-41804, 2005.
  4. Lewis, K., Holstein, S.A., Hohl, R.J.: Lovastatin Alters the Isoprenoid Biosynthetic Pathway in Acute Myelogenous Leukemia Cells In Vivo, Leukemia Research, 29: 527-533, 2005.
  5. Tong, H., Holstein, S.A., Hohl, R.J.: Simultaneous Determination of Farnesyl an Geranylgeranyl Pyrophosphate Levels in Cultured Cells, Analytical Biochemistry, 336: 51-59, 2005.
  6. Kim, M., Kleckley, T., Wiemer, A.J., Holstein, S.A., Hohl, R.J., Wiemer, D.F.: "Synthesis and Activity of Fluorescent Isoprenoid Pyrophosphate Analogues", Journal of Organic Chemistry, 69: 8186-8193, 2004.
  7. Holstein, S.A., Hohl, R.J.: Omnipresent Isoprenoids: Remarkable Diversity of Form and Function, Lipids, 39 (4): 293-309, 2004.
  8. Ownby, S.E., Hohl, R. J.: Isoprenoid Alcohols Restore Protein Isoprenylation in Time-Dependent Manner Independent of Protein Synthesis, Lipids, 38, 687-804, 2003.
  9. Holstein, S.A., Hohl, R.J.: Monoterpene Regulation of Ras-Related Protein Expression. Journal of Lipid Research, 44: 1209-1215, 2003.
  10. Holstein, S.A., Wohlford-Lenane, C.L., Wiemer, D.F., Hohl, R.J.: Isoprenoid Pyrophosphate Analogues Regulate Expression of Ras-Related Proteins. Biochemistry, 42: 4384-4391, 2003.
  11. Chen, X., Wiemer, A.J., Hohl, R.J., Wiemer, D.F.: Stereoselective Synthesis and Bioactivity of the 5'-Hydroxy-5'-Phosponate Derivatives of Cytidine and Cytosine Arabinoside. The Journal of Organic Chemistry, 67: 9331-9339, 2002.
  12. Chen, X., Wiemer, A.J., Hohl, R.J., Wiemer, D.F.: Stereoselective Synthesis and Bioactivity of the 5'-Hydroxy-5'- Phosponate Derivatives of  Cytidine and Cytosine Arabinoside. The Journal of Organic Chemistry, 67: 9331-9339, 2002.

Links of Interest

Back to Hematology-Oncology Faculty List